Supply of 28 Million Flu Vaccine Doses This Year... MFDS Holds National Release Approval Briefing

[Image source=Yonhap News]

[Asia Economy Reporter Jo In-kyung] This year, a total of 28 million doses of influenza vaccines are expected to be supplied domestically.

The Ministry of Food and Drug Safety announced that it will hold the '2022 Influenza Vaccine National Release Approval Briefing' on the 2nd for seven domestic vaccine manufacturers and importers to ensure smooth supply of influenza vaccines during the recommended vaccination period of October to November.

The influenza vaccines distributed this year consist of a total of nine products: seven manufactured by five domestic companies and two imported products from two multinational pharmaceutical companies.

National release approval is a system in which the government comprehensively evaluates the Ministry of Food and Drug Safety's test results and the manufacturer's manufacturing and test data for each manufacturing unit (lot) of vaccines, botulinum toxin products, plasma fractionation products, etc., to verify the quality of the products once more before they are distributed in the market.

The Ministry of Food and Drug Safety plans to provide guidance at this briefing on ▲ major revisions to national release approval regulations ▲ 2022 national release approval plans ▲ precautions when preparing manufacturing and quality control summaries ▲ influenza vaccine supply and procurement plans.

The Ministry explained, "If vaccines with the same manufacturing number as those already approved for release are imported on different days, testing is exempted, and if finished pharmaceuticals are continuously manufactured from the same final bulk, content testing is exempted from the second manufacturing number onward, operating the system reasonably to enable rapid release."

This content was produced with the assistance of AI translation services.